Oral bisphosphonates reduce the risk of clinical fractures in glucocorticoid-induced osteoporosis in clinical practice

被引：0
|
作者：
T. Thomas
S. Horlait
J. D. Ringe
A. Abelson
D. T. Gold
P. Atlan
J. L. Lange
机构：
[1] University Hospital of Saint-Etienne,INSERM U1059, Rheumatology Department
[2] Warner Chilcott,Medizinische Klinik IV (Osteology, Rheumatology), Klinikum Leverkusen
[3] University of Cologne,undefined
[4] Cleveland Clinic Foundation,undefined
[5] Duke University Medical Center,undefined
[6] Procter & Gamble,undefined
来源：
Osteoporosis International | 2013年 / 24卷
关键词：
Bisphosphonates; Clinical fractures; Glucocorticoid-induced osteoporosis; Risk reduction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：263 / 269
页数：6
相关论文
共 50 条
  • [41] Prophylaxis and Treatment of Glucocorticoid-induced Osteoporosis
    Oelzner, Peter
    Wolf, Gunter
    AKTUELLE RHEUMATOLOGIE, 2017, 42 (03) : 233 - 244
  • [42] Glucocorticoid-induced osteoporosis: pathophysiology and therapy
    E. Canalis
    G. Mazziotti
    A. Giustina
    J. P. Bilezikian
    Osteoporosis International, 2007, 18 : 1319 - 1328
  • [43] Prevention and treatment of glucocorticoid-induced osteoporosis
    Lane, NF
    Lukert, B
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 1999, 5 (05) : S16 - S22
  • [44] Zebrafish models for glucocorticoid-induced osteoporosis
    Lin, Wen-Ying
    Dharini, Kameshwara Kumar
    Peng, Cheng-Huan
    Lin, Chung-Yen
    Yeh, Kuang-Ting
    Lee, Wen-Chih
    Lin, Ming-Der
    TZU CHI MEDICAL JOURNAL, 2022, 34 (04): : 373 - 380
  • [45] Glucocorticoid-induced osteoporosis: Prevention and treatment
    Werth, VP
    REVUE DU RHUMATISME, 1997, 64 (06): : S84 - S88
  • [46] Treatment options for glucocorticoid-induced osteoporosis
    Chiodini, Iacopo
    Merlotti, Daniela
    Falchetti, Alberto
    Gennari, Luigi
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (06) : 721 - 732
  • [47] Glucocorticoid-induced osteoporosis: pathogenesis and management
    Junji Nishimura
    Shoichiro Ikuyama
    Journal of Bone and Mineral Metabolism, 2000, 18 : 350 - 352
  • [48] Advances in treatment of glucocorticoid-induced osteoporosis
    Hsu, Emory
    Nanes, Mark
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2017, 24 (06) : 411 - 417
  • [49] Denosumab in the treatment of glucocorticoid-induced osteoporosis
    Benlidayi, Ilke Coskun
    RHEUMATOLOGY INTERNATIONAL, 2018, 38 (11) : 1975 - 1984
  • [50] Therapeutic patenting for glucocorticoid-induced osteoporosis
    Cooper, MS
    Stewart, PM
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (06) : 847 - 857
12345